Dermatology · 5 min read
Vitiligo: What Causes White Patches and What Treatments Actually Work

Vitiligo is an autoimmune skin condition, not an infection or a hygiene problem. Here is what we know about causes, what treatments have evidence, and when to get seen.
Dr. Jezwah Harris · October 21, 2026
If you have noticed smooth, pale patches of skin that were not there before, you are not alone, and you did not do anything to cause them. Vitiligo is a chronic autoimmune condition in which the immune system attacks the cells that make skin color. It is not contagious, and it is not a hygiene problem. This guide explains what is going on, what treatments have real evidence behind them, and when it is worth getting seen.
What vitiligo is
Skin gets its color from cells called melanocytes. In vitiligo, those cells are damaged or lost in certain areas, so the skin there loses pigment. The patches are usually sharply defined and often show up on the hands, face, knees, elbows, and around the eyes and mouth. Hair growing in a patch can turn white too.
It is more common than many people expect. A large systematic review estimated that about 0.36 percent of people worldwide have physician-diagnosed vitiligo, and that it is more common in adults than in children (Akl et al., Lancet Public Health00026-4)). It can start at any age and affects all skin tones, though the contrast is easier to see on darker skin.
What causes it
We do not have one clean answer. Vitiligo seems to come from a mix of genes, immune activity, and triggers that vary from person to person. What we can say is that immune signaling plays a central role, and that is the reason newer treatments target the immune pathway in the skin.
Vitiligo also tends to travel with other autoimmune conditions, such as thyroid disease. If you have vitiligo, it is reasonable to ask whether a thyroid check makes sense for you. We can talk through that at a visit.
How we diagnose it
Most of the time, diagnosis starts with a look and a conversation. We ask when the patches appeared, whether they are growing, whether anyone in your family has vitiligo or autoimmune disease, and whether you had a sunburn, injury, or major stress beforehand. Clear photos in good light help a lot.
Other conditions can cause pale patches, including fungal infections and eczema that has left lighter skin behind. If the picture is not clear, we may recommend labs or a referral for an exam or a biopsy.
Treatments that have evidence
No single treatment works for everyone, and most take months to judge. Here is how the main options stack up.
Topical anti-inflammatory medicines. Prescription steroid creams and calcineurin inhibitors such as tacrolimus are common first steps, and we pick them based on where the patches are. Steroids are usually kept to short courses on the body and used carefully on the face, because long use can thin the skin.
Ruxolitinib cream. This is a topical Janus kinase (JAK) inhibitor designed to calm the immune activity that drives vitiligo in the skin. In two phase 3 trials with 674 people aged 12 and older, about 30 percent of those using the cream reached a 75 percent improvement in facial pigmentation at 24 weeks, compared with roughly 7 to 11 percent using a plain cream. The most common side effects were acne and itching where it was applied (Rosmarin et al., NEJM). That means most people did not reach that mark by week 24, and the trial authors note that longer studies are needed. We tell you both halves of that result.
Narrowband UVB phototherapy. Light treatment is a long-standing standard of care. Expert recommendations on dosing and frequency exist (Vitiligo Working Group, JAAD), and reviews describe it as one of the safest and most effective options, with home devices gaining ground (Khanna and Khandpur). Phototherapy needs a device, so we refer you to a practice or a home-unit program rather than providing it ourselves.
Surgical options. For patches that have been stable for a long time and have not responded to other care, procedures such as skin grafting and cell suspensions can help. A pooled analysis of 117 studies found that most people had at least half of the treated area repigment (Ju et al., JAMA Dermatology). Results depend on age, location, and cost, and these procedures happen at a specialty practice.
The part people do not always say out loud
Vitiligo is not dangerous, but it can weigh on you. A pooled analysis of 15 studies found that about 36 percent of people with vitiligo had anxiety (Kussainova et al., PLoS One). If the patches are affecting your confidence, your relationships, or your sleep, that counts as a reason to be seen, and we can help with that part of care too.
What you can do in the meantime
Treatment works best alongside a few steady habits. Keep notes on when new patches appear, since a link to a sunburn, a skin injury, or a stressful stretch can help us spot triggers. Ask us about sun protection for the affected areas, because pale patches have less natural color to shield them. And be patient with the process: repigmentation tends to start around hair follicles as small freckle-like dots, and that early sign is a good one.
If you take other medicines or have a history of skin cancer, tell us up front. Those details change which treatments make sense for you, and we would rather match the plan to you than to a template.
What to do next
Getting seen early gives you the most options, since patches that are still active often respond better than very old ones. Take a few photos in natural light now, and again each month, so we can see whether anything is changing.
We see vitiligo as part of our medical dermatology care, by video, with referrals when you need a procedure or in-clinic light therapy. Most major plans are accepted, including Medicare. You can learn more and book at /conditions/dermatology.
Questions
Is vitiligo contagious?
No. Vitiligo is an autoimmune condition, and you cannot catch it from touching someone or sharing items with them. It is not caused by poor hygiene or diet.
Can vitiligo be cured?
There is no cure today, but treatment can restore pigment in many people and slow new patches. Results vary by body area and by how long the patches have been there, and pigment can fade again after treatment stops.
Will my vitiligo spread?
It is hard to predict. Some people have a few stable patches for years, while others have patches that keep appearing. Seeing us early helps, because active vitiligo tends to respond better to treatment than long-standing patches.
Is ruxolitinib cream safe?
In the phase 3 trials, the most common side effects were acne and itching where the cream was applied. It carries boxed warnings shared by other drugs in its class, so we review your health history and your treated area before prescribing.
Can telehealth diagnose vitiligo?
Often, yes. Vitiligo has a recognizable look, and a clear video visit with good photos plus your history is usually enough to start. If we need a skin exam under special light, a biopsy, or in-clinic phototherapy, we refer you to a practice that offers it.
Does vitiligo affect mental health?
It can. A pooled analysis of studies found that about 36 percent of people with vitiligo had anxiety, so it is worth raising how you are feeling, not only how your skin looks.
Sources
- Rosmarin D, Passeron T, Pandya AG, et al. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. N Engl J Med (2022)
- Mohammad TF, Al-Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo. J Am Acad Dermatol (2017)
- Ju HJ, Bae JM, Lee RW, et al. Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatol (2021)
- Akl J, Lee S, Ju HJ, et al. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health (2024)
- Kussainova A, Kassym L, Akhmetova A, et al. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS One (2020)
- Khanna U, Khandpur S. What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo? Indian Dermatol Online J (2019)